RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.95B
1-Year Est. Return 81.42%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+81.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.95B
AUM Growth
+$238M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
110
New
Increased
Reduced
Closed

Top Buys

1
+$13.8M
2
+$8.05M
3
+$6.64M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$6.45M
5
IMNM icon
Immunome
IMNM
+$6.1M

Top Sells

1
+$56.2M
2
+$33.8M
3
+$29.7M
4
INSM icon
Insmed
INSM
+$12M
5
MREO
Mereo BioPharma
MREO
+$9.42M

Sector Composition

1 Healthcare 98.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$992B
$113M 5.81%
105,400
RVMD icon
2
Revolution Medicines
RVMD
$19.7B
$106M 5.46%
1,335,270
ARGX icon
3
argenx
ARGX
$47.5B
$86.8M 4.45%
103,250
-39,500
TVTX icon
4
Travere Therapeutics
TVTX
$2.67B
$84.5M 4.33%
2,210,322
+45,549
MDGL icon
5
Madrigal Pharmaceuticals
MDGL
$9.81B
$81.3M 4.17%
139,618
+1,872
RYTM icon
6
Rhythm Pharmaceuticals
RYTM
$6.19B
$74.4M 3.82%
695,010
-22,092
EXAS icon
7
Exact Sciences
EXAS
$19.7B
$61.1M 3.14%
601,800
+8,300
MIRM icon
8
Mirum Pharmaceuticals
MIRM
$5.53B
$60.2M 3.09%
762,294
+1,168
INSM icon
9
Insmed
INSM
$31.8B
$55.6M 2.85%
319,250
-65,750
GPCR icon
10
Structure Therapeutics
GPCR
$4.45B
$52M 2.67%
748,236
-202,918
ISRG icon
11
Intuitive Surgical
ISRG
$179B
$46.4M 2.38%
82,000
CDTX
12
DELISTED
Cidara Therapeutics
CDTX
$45.3M 2.32%
204,878
-44,524
ASND icon
13
Ascendis Pharma
ASND
$14.3B
$43.4M 2.23%
203,500
-11,000
IRTC icon
14
iRhythm Holdings
IRTC
$4.32B
$41.7M 2.14%
235,000
KYMR icon
15
Kymera Therapeutics
KYMR
$7.31B
$38.7M 1.98%
496,871
+46,497
BSX icon
16
Boston Scientific
BSX
$114B
$38M 1.95%
399,050
+38,800
PEN icon
17
Penumbra
PEN
$13.5B
$37.5M 1.92%
120,500
XENE icon
18
Xenon Pharmaceuticals
XENE
$3.34B
$35.3M 1.81%
787,788
-63,956
SRRK icon
19
Scholar Rock
SRRK
$4.52B
$32.3M 1.66%
733,477
-60,656
COGT icon
20
Cogent Biosciences
COGT
$6.31B
$30.2M 1.55%
849,030
-159,278
RARE icon
21
Ultragenyx Pharmaceutical
RARE
$2.26B
$29.1M 1.5%
1,267,241
+20,900
VERA icon
22
Vera Therapeutics
VERA
$2.9B
$28.8M 1.48%
568,579
-48,817
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$44.2B
$28.3M 1.45%
71,250
-3,000
FOLD icon
24
Amicus Therapeutics
FOLD
$4.51B
$27.5M 1.41%
1,929,931
-17,443
XBI icon
25
State Street SPDR S&P Biotech ETF
XBI
$8.13B
$27.1M 1.39%
222,000
+70,250
1
2 3 4 5